Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kowa Research Institute, Inc.
Age
18–45
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subject is a healthy adult male or female volunteer aged 18 to 45 years, inclusive
Subject has a body mass index of 18 to 32 kg/m2, inclusive
Subject is able and willing to abstain from alcohol, grapefruit, caffeine
Subject has no clinically relevant abnormalities on the basis of medical history, physical examination, and vital signs
You may not be if
Subject has clinically relevant out-of-range prothrombin time (PT), activated partial thromboplastin time, fibrinogen, protein C, or protein S
Subject has abnormal prolongation of bleeding time at Screening
Subject has hematuria on urinalysis
Subject has personal or family history of coagulation or bleeding disorders
Clareo Health | Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers
